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1. INTRODUCTION {#hsr2137-sec-0005}
===============

Acute respiratory infections (ARIs) are responsible for elevated childhood morbidity and mortality globally,[1](#hsr2137-bib-0001){ref-type="ref"}, [2](#hsr2137-bib-0002){ref-type="ref"} accounting for approximately four million deaths among children aged younger than 5 years in 2010 and resulting in substantial burden of healthcare systems.[3](#hsr2137-bib-0003){ref-type="ref"}, [4](#hsr2137-bib-0004){ref-type="ref"} In developing countries, ARIs account for 19% of all deaths among children aged younger than 5 years and 8.2% of all disabilities and premature deaths.[5](#hsr2137-bib-0005){ref-type="ref"}, [6](#hsr2137-bib-0006){ref-type="ref"} Therefore, data on the epidemiology and seasonality of ARI are important to develop control and prevention strategies.[7](#hsr2137-bib-0007){ref-type="ref"}

In Niger, the estimated mortality rate among children aged younger than 5 years was 114 per 1000 in 2012 (UNICEF child mortality estimate), and more than 80% of these deaths were associated with malaria, respiratory infections, and diarrhea. According to the 2012 Niger health statistics yearbook, the estimated case fatality proportion associated with respiratory infections was 8.7%.

In the absence of laboratory diagnosis, it is difficult to clinically differentiate between ARI‐related causative pathogens, due to similarities of symptoms.[8](#hsr2137-bib-0008){ref-type="ref"}, [9](#hsr2137-bib-0009){ref-type="ref"} The main causative agents of ARI are viruses and bacteria.[10](#hsr2137-bib-0010){ref-type="ref"} Major viruses include respiratory syncytial virus (RSV), human rhinovirus (HRV), influenza virus (INF) types A and B, human adenovirus (HAV), human parainfluenza virus (HPIV), human metapneumovirus (HMPV), and human coronavirus (HCOV), while major bacterial pathogens include *Streptococcus pneumoniae*, *Staphylococcus aureus,* and *Haemophilus influenzae.* [11](#hsr2137-bib-0011){ref-type="ref"}, [12](#hsr2137-bib-0012){ref-type="ref"}, [13](#hsr2137-bib-0013){ref-type="ref"}

In Niger, there is scarcity of data on ARIs, although a routine influenza surveillance system exists. INF has been detected in 11% of samples from children aged younger than 5 years hospitalized with severe acute respiratory illness (SARI).[14](#hsr2137-bib-0014){ref-type="ref"} Knowledge on the etiology of ARI in Niger could inform the selection of other important pathogens to be included in routine surveillance and improve the clinical management of patients.

This study aims to describe the viral and bacterial infections among children aged younger than 5 years hospitalized with febrile ARI at two national hospitals of Niamey, the capital city of Niger, and the reported clinical procedures.

2. METHODS {#hsr2137-sec-0006}
==========

2.1. Study design and setting {#hsr2137-sec-0007}
-----------------------------

We conducted a prospective study among children aged younger than 5 years hospitalized with febrile ARI between January and December 2015. Niger has four distinct seasons as categorized by the national directorate of meteorology: the cold season (mid‐December to mid‐February), the dry season (mid‐February to May), the rainy season (June to September), and the hot season (October to mid‐December).[15](#hsr2137-bib-0015){ref-type="ref"}

This study was part of the "TOTAL Niger Infection Respiratoire Aiguë" (TONIRA) Project, which was funded by the TOTAL Corporate Foundation in order to strengthen medical care of febrile ARI among children aged younger than 5 years. The study was conducted at the pediatric wards of two national tertiary hospitals situated in Niamey, namely, the Hôpital National de Niamey (HNN) and the Hôpital National Lamordé (HNL). These two hospitals provide general health care to the population of Niamey estimated at 1.1 million in 2015, as well as to patients referred from across the country. Laboratory detection of respiratory viruses and bacteria were conducted at the Centre de Recherche Médicale et Sanitaire (CERMES), Niamey, Niger (the National Reference Laboratory for influenza).

Demographic and clinical data, as well as the use of antibiotics before and during admission, were collected using standard data collection forms. Malaria testing was implemented on site using thick blood film microscopy. Chest X‐rays were performed at the discretion of the attending physician, and typical abnormal radiological findings assessed included pulmonary opacities, acute bronchiolitis, and enlargement of intercostal spaces. Malnutrition was determined using the ratio of weight for height, and its level was classified as moderate or severe by the attending physician using national standards based on the 2010 Technical Guidelines for Integrated Disease Surveillance and Response in the African Region (Retrieved from <https://www.afro.who.int/sites/default/files/2017-06/IDSR-Technical-Guidelines_Final_2010_0.pdf> [)]{.ul}. Febrile ARI in conjunction with malaria, malnutrition, and diarrhea were assessed during admission using a standardized case investigation form. In‐hospital outcome (ie., discharge, referral, or death) was recorded for all enrolled patients.

2.2. Case definition {#hsr2137-sec-0008}
--------------------

A febrile ARI case was defined as a hospitalized child aged younger than 5 years with onset of fever 38°C or higher and cough within 10 days prior to admission and at least one of the following signs: inability to drink or breastfeed, lethargy, vomiting, convulsions, nasal flaring, chest indrawing, stridor in a calm child, or tachypnea.

2.3. Sampling and laboratory testing {#hsr2137-sec-0009}
------------------------------------

Nasopharyngeal swabs were collected from all enrolled patients, placed in universal transport medium, stored at 4 to 8°C, and transported to CERMES within 72 hours of collection, for testing. Respiratory samples were tested for INF types A and B; HPIV types 1 to 4; HCoV NL63, 229E, OC43, and HKU1; HMPV A and B; RSV A and B; human parechovirus (HPV); human enterovirus (HEV); HAV; human bocavirus (HBoV); HRV; *S pneumoniae*; *H influenzae* type B (Hib); *S aureus*; *Mycoplasma pneumoniae*; and *Chlamydia pneumoniae* using the RT‐qPCR Fast Track Diagnostic Respiratory pathogens 21 Plus kit from Bio‐Mérieux (catalog no. FTD 2+‐96/12), following the manufacturer\'s instructions. An internal control provided as part of the kit was used to monitor the sample extraction and reverse transcription. RT‐qPCR was performed using the FTD Respiratory pathogens 21 plus kit as follows: the reaction volume for each test was 25 μL, consisting of 10 μL of nucleic acid and 15 μL of buffer/enzyme mix from the AgPath‐ID One‐Step RT‐PCR kit (Ambion, Life Technologies, USA, Catalog number 4387424). Amplification was performed using ABI 7500 Fast real‐time PCR system thermocycler (Applied Biosystems, USA,) and the following cycling conditions were used: 50°C at 15 minutes for reverse transcription, 95°C at 10 minutes for enzyme activation, and 40 cycles of 95°C at 8 seconds and 60°C at 34 seconds for amplification. The fluorescence was assessed at the amplification step. The positive and negative virus plasmid controls provided in the kit were included in all runs to monitor assay performance.[16](#hsr2137-bib-0016){ref-type="ref"}

2.4. Statistical analysis {#hsr2137-sec-0010}
-------------------------

Viral and/or bacterial detection was reported as percentage positive, overall and within selected categories (eg, age groups and seasons). Children aged younger than 5 years were stratified into two age groups: infants (aged younger than 1 year) and young children (aged 1‐4 years), for comparability with other studies from Africa.[17](#hsr2137-bib-0017){ref-type="ref"}, [18](#hsr2137-bib-0018){ref-type="ref"}, [19](#hsr2137-bib-0019){ref-type="ref"}, [20](#hsr2137-bib-0020){ref-type="ref"} In addition, the majority of enrolled children were aged younger than 1 year hindering our ability to categorize age in smaller age groups. Stata version 14.2 (StataCorp, College Station, Texas, USA) was used for the analysis.

2.5. Ethical approval {#hsr2137-sec-0011}
---------------------

The protocol was approved by the National Ethical Consultative Committee (CCNE) of Niger and by the Clinical Research Committee (CoRC) of the Institut Pasteur, Paris. Proxy informed consent was obtained from parents or legal guardians of children. All children who did not meet the case definition or for whom verbal consent was not obtained were not included in the study.

3. RESULTS {#hsr2137-sec-0012}
==========

3.1. Study population {#hsr2137-sec-0013}
---------------------

Between January and December 2015, we enrolled and tested 638 children aged younger than 5 years. Of these, 411 (64.4%) were aged younger than 1 year, 347 (54.4%) were male, and 365 (57.3%) were admitted at the HNN. Of the comorbidities investigated, malaria, malnutrition, and diarrhea were diagnosed in 100 (15.7%), 114 (17.9%), and 114 (17.9%) case patients, respectively. Of the 114 malnourished children identified, 74 (64.9%) had severe malnutrition (Table [1](#hsr2137-tbl-0001){ref-type="table"}). Chest X‐rays were performed on 301 (47.2%) case patients. Of these patients, 231 (76.7%) had abnormal radiological findings, of which the most common were pulmonary opacity (106; 45.9%), extension of the intercostal space (99; 42.8%), and bronchiolitis (21; 9.1%). One hundred thirty‐five (21.2%) children received antibiotic treatment within 3 days prior to admission, and 572 (89.7%) children were prescribed antibiotic treatment during admission. The in‐hospital case fatality proportion was 2.4% (15/638) overall; 2.9% (12/411) and 1.3% (3/227) among children aged younger than 1 and 1 to 4 years, respectively.

###### 

Detection of respiratory viruses and bacteria among children aged \<5 years hospitalized with febrile acute respiratory infection in Niamey, Niger, 2015

  Characteristics                                            Population N (%)   Detection n (%)                             
  ---------------------------------------------------------- ------------------ ----------------- ------------ ------------ ------------
  Total                                                      638                496 (77.7)        195 (30.6)   126 (19.7)   175 (27.4)
  Age (in y)                                                                                                                
  \<1                                                        411 (64.4)         327 (79.6)        141 (34.3)   70 (17.0)    116 (28.2)
  1‐4                                                        227 (35.6)         169 (74.4)        54 (23.8)    56 (24.7)    59 (26.0)
  Sex                                                                                                                       
  Female                                                     291 (45.6)         231 (79.4)        86 (29.5)    61 (21.0)    84 (28.9)
  Male                                                       347 (54.4)         265 (76.4)        109 (31.4)   65 (18.7)    91 (26.2)
  Season of the year[a](#hsr2137-note-0001){ref-type="fn"}                                                                  
  Cold                                                       108 (84.3)         64 (59.3)         27 (25.0)    25 (23.1)    12 (11.1)
  Dry                                                        213 (33.4)         175 (82.2)        80 (37.6)    28 (13.1)    67 (31.5)
  Rainy                                                      191 (29.9)         160 (83.8)        40 (20.9)    57 (29.8)    63 (33.0)
  Hot                                                        126 (19.8)         97 (77.0)         48 (38.1)    16 (12.7)    33 (26.2)
  Malaria                                                                                                                   
  No                                                         538 (84.3)         415 (77.1)        159 (29.6)   110 (20.4)   146 (27.1)
  Yes                                                        100 (15.7)         81 (81.0)         36 (36.0)    16 (16.0)    29 (29.0)
  Diarrhea                                                                                                                  
  No                                                         524 (82.1)         407 (77.7)        164 (31.3)   100 (19.1)   143 (27.3)
  Yes                                                        114 (17.9)         89 (78.1)         31 (27.2)    26 (22.8)    32 (28.1)
  Malnutrition                                                                                                              
  No                                                         524 (82.1)         406 (77.5)        154 (29.4)   102 (19.5)   150 (28.6)
  Moderate                                                   40 (6.3)           34 (85.0)         17 (42.5)    5 (12.5)     12 (30.0)
  Severe                                                     74 (11.6)          56 (75.7)         24 (32.4)    19 (25.7)    13 (17.6)
  Antibiotics on admission                                                                                                  
  No                                                         66 (10.3)          50 (75.8)         20 (30.3)    9 (13.6)     21 (31.8)
  Yes                                                        572 (89.7)         446 (78.0)        175 (30.6)   117 (20.4)   154 (26.9)
  Death                                                                                                                     
  No                                                         623 (97.6)         482 (77.4)        188 (30.2)   122 (19.6)   172 (27.6)
  Yes                                                        15 (2.4)           14 (93.3)         7 (46.7)     4 (26.7)     3 (20.0)

When the patient was hospitalized.

3.2. Detection of viral and bacterial agents {#hsr2137-sec-0014}
--------------------------------------------

Overall, 496/638 (77.7%) specimens tested positive for at least one respiratory virus or bacterium (Table [1](#hsr2137-tbl-0001){ref-type="table"}). Of the 496 positive specimens, 195 (39.3%) tested positive for respiratory viruses only, 126 (25.4%) tested positive for respiratory bacteria only, and 175 (35.3%) tested positive for both respiratory viruses and bacteria. Single virus or bacterium was detected in 229/496 (46.2%) positive specimens, of which 140 (61.1%) were single viral infections (Figure [1](#hsr2137-fig-0001){ref-type="fig"}). The number of viral and/or bacterial detection among positive specimens ranged between 1 and 5.

![Detection (including codetection) of respiratory viruses and bacteria among children aged \<5 years hospitalized with febrile acute respiratory infection in Niamey, Niger, 2015 (the size of the circles is proportional to the number of specimens within each category; percentages are expressed over total number of positive specimens: 496)](HSR2-2-e137-g001){#hsr2137-fig-0001}

Antibiotics were prescribed to 89.7% (175/195), 92.8% (117/126), and 88.0% (154/175) of patients with viral only, bacterial only, or viral and bacterial detection, respectively.

3.3. Individual detection of respiratory viruses {#hsr2137-sec-0015}
------------------------------------------------

Overall, respiratory viruses were detected in 370/638 (58.0%) specimens. RSV (149/638; 23.3%), HPIV types 1 to 4 (78/638; 12.2%), HRV (62/638; 9.4%), HAV (60/638; 9.4%), and INF (52/638; 8.1%) were the predominant viruses detected (Table [2](#hsr2137-tbl-0002){ref-type="table"}). Of the HPIV‐positive specimens, HPIV‐3 was the most commonly detected one (48/78; 61.5%), whereas INF type A predominated among the influenza‐positive specimens (46/52; 88.5%). HCoVs were detected in 8.0% (51/638) of specimens, and OC43 was the mostly detected one (44/51; 86.3%). HMPV, HBoV, and HEV were detected individually in less than 5% of specimens. HPV was the least commonly detected respiratory virus (1/638; 0.2%).

###### 

Detection of individual respiratory viruses among children aged \<5 years hospitalized with febrile acute respiratory infection in Niamey, Niger, 2015

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics                                            Detection\                                                                                                         
                                                             n (%)                                                                                                              
  ---------------------------------------------------------- ------------ ----------- ----------- ----------- ----------- ----------- ---------- ---------- --------- --------- ------------
  Total (N = 638)                                            149 (23.3)   78 (12.2)   62 (9.7)    60 (9.4)    52 (8.1)    51 (8.0)    28 (4.4)   22 (3.4)   8 (1.2)   1 (0.2)   370 (58.0)

  Age (in y)                                                                                                                                                                    

  \<1 (N = 411)                                              119 (28.9)   59 (14.4)   38 (9.2)    39 (9.5)    32 (7.8)    37 (9.0)    19 (4.6)   18 (4.4)   5 (1.2)   1 (0.2)   257 (62.5)

  1‐4 (N = 227)                                              30 (13.2)    19 (8.4)    24 (10.6)   21 (9.2)    20 (8.8)    14 (6.2)    9 (4.0)    4 (1.8)    3 (1.3)   0 (0.0)   113 (49.8)

  Sex                                                                                                                                                                           

  Female (N = 291)                                           65 (22.3)    39 (13.4)   25 (8.6)    25 (8.6)    26 (8.9)    26 (8.9)    14 (4.8)   9 (3.9)    2 (0.7)   0 (0.0)   170 (58.4)

  Male (N = 347)                                             84 (24.2)    39 (11.2)   37 (10.7)   35 (10.1)   26 (7.5)    25 (7.2)    14 (4.0)   13 (3.7)   6 (1.7)   1 (0.3)   200 (57.6)

  Season of the year[a](#hsr2137-note-0003){ref-type="fn"}                                                                                                                      

  Cold (N = 108)                                             12 (11.1)    4 (3.7)     3 (2.8)     4 (3.7)     16 (14.8)   4 (3.7)     2 (1.8)    4 (3.7)    1 (0.9)   0 (0.0)   39 (36.1)

  Dry (N = 213)                                              63 (29.6)    44 (20.7)   24 (11.3)   24 (11.3)   17 (8.0)    31 (14.5)   11 (5.1)   4 (1.9)    1 (0.5)   1 (0.5)   147 (69.0)

  Rainy (N = 191)                                            18 (9.4)     19 (9.9)    24 (12.6)   22 (11.5)   13 (6.8)    16 (8.4)    4 (2.1)    12 (6.3)   6 (3.1)   0 (0.0)   103 (53.9)

  Hot (N = 126)                                              56 (44.4)    11 (8.7)    11 (8.7)    10 (7.9)    6 (4.8)     0 (0.0)     11 (8.7)   2 (1.6)    0 (0.0)   0 (0.0)   81 (64.3)

  Malaria                                                                                                                                                                       

  No (N = 538)                                               116 (21.6)   63 (11.7)   47 (8.7)    49 (9.1)    46 (8.5)    48 (8.9)    23 (4.3)   20 (3.6    6 91.1)   1 (0.2)   305 (56.7)

  Yes (N = 100)                                              33 (33.0)    15 (15.0)   15 (15.0)   11 (11.0)   6 (6.00)    3 (3.0)     5 (5.0)    2 (2.0)    2 (2.0)   0 (0.0)   65 (65.0)

  Diarrhea                                                                                                                                                                      

  No (N = 524)                                               126 (24.0)   67 (12.8)   50 (9.5)    48 (9.2)    42 (8.0)    37 (7.1)    24 (4.6)   18 (3.4)   8 (1.5)   0 (0.0)   307 (58.6)

  Yes (N = 114)                                              23 (20.2)    11 (9.6)    12 (10.5)   12 (10.5)   10 (8.8)    14 (12.3)   4 (3.5)    4 (3.5)    0 (0.0)   1 (0.9)   63 (55.3)

  Malnutrition                                                                                                                                                                  

  No (N = 524)                                               124 (23.7)   65 (12.4)   48 (9.2)    42 (8.1)    42 (8.0)    41 (7.8)    25 (4.8)   20 (3.8)   6 (1.1)   1 (0.2)   304 (58.0)

  Moderate (N = 40)                                          12 (30.0)    5 (12.5)    7 (17.5)    7 (17.5)    6 (15.0)    5 (12.5)    1 (2.5)    2 (5.0)    0 (0.0)   0 (0.0)   29 (72.5)

  Severe (N = 74)                                            13 (17.6)    8 (10.8)    7 (9.5)     11 (14.9)   4 (5.4)     5 (6.8)     2 (2.7)    0 (0.0)    2 (2.7)   0 (0.0)   37 (50.0)

  Antibiotics on admission                                                                                                                                                      

  No (N = 66)                                                17 (15.8)    9 (13.6)    10 (15.1)   6 (9.1)     6 (9.1)     8 (12.1)    5 (7.6)    2 (3.0)    0 (0.0)   0 (0.0)   41 (62.1)

  Yes (N = 572)                                              132 (23.1)   69 (12.1)   59 (9.1)    54 (9.4)    46 (8.0)    43 (7.5)    23 (4.2)   20 (3.5)   8 (1.4)   1 (0.2)   329 (57.5)

  Death                                                      1.00         .704        .002        .644        1.000       .340        1.000      1.000      1.000     1.000     .602

  No (N = 623)                                               146 (23.4)   76 (12.2)   56 (9.0)    58 (9.3)    51 (8.2)    49 (7.9)    28 (4.5)   22 (3.5)   8 (1.3)   1 (0.2)   360 (57.8)

  Yes (N = 15)                                               3 (20.0)     2 (13.3)    6 (40.0)    2 (13.3)    1 (6.7)     2 (13.3)    0 (0.0)    0 (0.0)    0 (0.0)   0 (0.0)   10 (66.7)

  Bacteria                                                                                                                                                                      

  Any (N = 301)                                              67 (22.3)    32 (10.6)   30 (10.0)   31 (10.3)   25 (8.3)    23 (7.6)    12 (4.0)   13 (4.3)   5 (1.7)   1 (0.3)   175 (58.1)

  Spneu (N = 249)                                            50 (20.1)    28 (11.2)   24 (9.6)    28 (11.2)   20 (8.1)    18 (7.2)    11 (4.4)   10 (4.0)   3 (1.2)   1 (0.4)   142 (57.0)

  Saur (N = 112)                                             26 (23.2)    10 (8.9)    11 (9.8)    9 (8.0)     8 (7.1)     8 (7.1)     5 (4.5)    7 (6.2)    3 (2.7)   1 (0.9)   65 (58.0)

  Hib (N = 16)                                               2 (12.5)     3 (18.7)    2 (12.5)    2 (12.5)    4 (25.0)    0 (0.0)     0 (0.0)    0 (0.0)    0 (0.0)   0 (0.0)   8 (50.0)

  Mpneu (N = 4)                                              0 (0.0)      0 (0.0)     1 (25.0)    1 (25.0)    1 (25.0)    0 (0.0)     0 (0.0)    0 (0.0)    0 (0.0)   0 (0.0)   2 (50.0)

  Cpneu (N = 2)                                              1 (50.0)     0 (0.0)     0 (0.0)     0 (0.0)     0 (0.0)     1 (50.0)    0 (0.0)    0 (0.0)    0 (0.0)   0 (0.0)   2 (100.0)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: Cpneu, *Chlamydia pneumonia*; HAV, human andenovirus; HBoV, human bocavirus; HCoV, human coronavirus; HEV, human enterovirus; Hib, *Haemophilus influenzae* type B; HMPV, human metapneumovirus; HPV, human parechovirus; HPVI, human parainfluenza virus; HRV, human rhinovirus; INF, influenza virus; Mpneu, *Mycoplasma pneumoniae*; RSV, respiratory syncytial virus; Saur, *Staphylococcus aureus*; Spneu, *Streptococcus pneumoniae.*

When the patient was hospitalized.

Of the specimens that tested positive for at least one respiratory virus, two or more respiratory viruses were detected in 104/370 (28.1%) specimens, of which dual detection occurred in 72/104 (69.2%) specimens. RSV (95/149; 63.8%), HMPV (17/28; 60.7%), and INF (31/52; 59.6%) were mostly detected in specimens with single viral infection, whereas HPV (1/1; 100.0%), HEV (6/8; 75.0%), HAV (38/60; 63.3%), HBoV (13/22; 59.1%), and HRV (34/62; 54.8%) were mostly detected in specimens with two or more viral infections (Figure [2](#hsr2137-fig-0002){ref-type="fig"}A). The number of viral detections among virus‐positive specimens ranged between 1 and 4. Among patients with abnormal radiological findings, respiratory viruses were most commonly detected among patients with bronchiolitis (19/21; 90.5%). RSV and HPIV were mostly detected among children aged younger than 1 compared with 1 to 4 years (Table [2](#hsr2137-tbl-0002){ref-type="table"}).

![Proportion of single and multiple (A) viral and (B) bacterial detections among children aged \<5 years hospitalized with febrile acute respiratory infection in Niamey, Niger, 2015. HAV, human adenovirus; HBoV, human bocavirus; HCoV, human coronavirus; HEV, human enterovirus; HPIV, human parainfluenza virus; HPV, human parechovirus; HRV, human rhinovirus; INF, influenza virus; RSV, respiratory syncytial virus](HSR2-2-e137-g002){#hsr2137-fig-0002}

Regarding seasonality, INF was mostly detected during the cold season, HPIV and HCoV were mostly detected during the dry season, HRV was mostly detected during the rainy season, and RSV and HMPV were mostly detected during the hot season (Table [2](#hsr2137-tbl-0002){ref-type="table"} and Figure [3](#hsr2137-fig-0003){ref-type="fig"}A).

![Weekly number of specimens positive for respiratory (A) viruses and (B) bacteria in Niamey, Niger, 2015](HSR2-2-e137-g003){#hsr2137-fig-0003}

3.4. Individual detection of respiratory bacteria {#hsr2137-sec-0016}
-------------------------------------------------

Overall, respiratory bacteria were detected in 301/638 (47.2%) specimens. *S pneumoniae* (249/638; 39.0%) was the most frequently detected bacterium, followed by *S aureus* (112/638; 12.2%) and Hib (16/638; 2.5%) (Table [3](#hsr2137-tbl-0003){ref-type="table"}). *M pneumoniae* and *C pneumoniae* were detected individually in less than 1% of specimens.

###### 

Detection of individual respiratory bacteria among children aged \<5 years hospitalized with febrile acute respiratory infection in Niamey, Niger, 2015

  Characteristics                                            Detection n (%)                                               
  ---------------------------------------------------------- ----------------- ------------ ---------- --------- --------- ------------
  Total (N = 638)                                            249 (39.0)        112 (17.5)   16 (2.5)   4 (0.6)   2 (0.3)   301 (47.2)
  Age (in y)                                                                                                               
  \<1 (N = 411)                                              152 (37.0)        68 (16.5)    8 (1.9)    3 (0.7)   1 (0.2)   186 (45.3)
  1‐4 (N = 227)                                              97 (42.7)         44 (19.4)    8 (3.5)    1 (0.4)   1 (0.4)   115 (50.7)
  Sex                                                                                                                      
  Female (N = 291)                                           121 (41.6)        51 (17.5)    10 (3.4)   2 (0.7)   1 (0.3)   145 (49.8)
  Male (N = 347)                                             128 (36.9)        61 (17.6)    6 (1.7)    2 (0.6)   1 (0.3)   156 (45.0)
  Season of the year[a](#hsr2137-note-0005){ref-type="fn"}                                                                 
  Cold (N = 108)                                             31 (28.7)         11 (10.2)    3 (2.8)    0 (0.0)   0 (0.0)   37 (34.3)
  Dry (N = 213)                                              69 (32.4)         43 (20.2)    3 (1.4)    1 (0.5)   2 (0.9)   95 (44.6)
  Rainy (N = 191)                                            105 (55.0)        47 (24.6)    7 (3.7)    2 (1.0)   0 (0.0)   120 (62.8)
  Hot (N = 126)                                              44 (34.9)         11 (8.7)     3 (2.4)    2 (0.8)   0 (0.0)   49 (38.9)
  Malaria                                                                                                                  
  No (N = 538)                                               210 (39.0)        93 (17.3)    14 (2.6)   2 (0.4)   2 (0.4)   256 (47.6)
  Yes (N = 100)                                              39 (39.0)         19 (19.0)    2 (2.0)    2 (2.0)   0 (0.0)   45 (45.0)
  Diarrhea                                                                                                                 
  No (N = 524)                                               196 (37.4)        95 (18.1)    12 (2.3)   3 (0.6)   2 (0.4)   243 (46.4)
  Yes (N = 114)                                              53 (46.5)         17 (14.9)    4 (3.5)    1 (0.9)   0 (0.0)   58 (50.9)
  Malnutrition                                                                                                             
  No (N = 524)                                               208 (39.7)        95 (18.1)    14 (2.7)   4 (0.8)   2 (0.4)   252 (48.1)
  Moderate (N = 40)                                          14 (35.0)         6 (15.0)     0 (0.0)    0 (0.0)   0 (0.0)   17 (42.5)
  Severe (N = 74)                                            27 (36.5)         11 (14.9(    2 (2.7)    0 (0.0)   0 (0.0)   32 (43.2)
  Antibiotics on admission                                                                                                 
  No (N = 66)                                                21 (31.8)         15 (22.7)    0 (0.0)    0 (0.0)   1 (1.5)   30 (45.4)
  Yes (N = 572)                                              228 (39.9)        97 (17.0)    16 (2.8)   4 (0.7)   1 (0.2)   271 (47.4)
  Death                                                                                                                    
  No (N = 623)                                               243 (39.0)        111 (17.8)   16 (2.6)   3 (0.5)   2 (0.3)   294 (47.2)
  Yes (N = 15)                                               6 (40.0)          1 (6.7)      0 (0.0)    1 (6.7)   0 (0.0)   7 (46.7)
  Viruses                                                                                                                  
  Any (N = 370)                                              142 (38.4)        65 (17.6)    8 (2.2)    2 (0.5)   2 (0.3)   175 (47.3)
  RSV (N = 149)                                              50 (33.6)         26 (17.4)    2 (1.3)    0 (0.0)   1 (0.7)   67 (45.0)
  HPIV (N = 78)                                              28 (35.9)         10 (12.8)    3 (3.8)    0 (0.0)   0 (0.0)   32 (41.0)
  HRV (N = 62)                                               24 (38.7)         11 (17.7)    2 (3.2)    1 (1.6)   0 (0.0)   30 (48.4)
  HAV (N = 60)                                               28 (46.7)         9 (15.0)     2 (3.3)    1 (1.7)   0 (0.0)   31 (51.7)
  INF (N = 52)                                               20 (38.5)         8 (15.4)     4 (7.7)    1 (1.9)   0 (0.0)   25 (48.1)
  HCoV (N = 51)                                              18 (35.3)         8 (15.7)     0 (0.0)    0 (0.0)   1 (2.0)   23 (45.1)
  HMPV (N = 28)                                              11 (39.0)         5 (17.9)     0 (0.0)    0 (0.0)   0 (0.0)   12 (42.9)
  HBoV (N = 22)                                              10 (45.4)         7 (31.8)     0 (0.0)    0 (0.0)   0 (0.0)   13 (59.1)
  HPV (N=1)                                                  1 (100.0)         1 (100.0)    0 (0.0)    0 (0.0)   0 (0.0)   1 (100.0)

Abbreviations: HAV, human andenovirus; HBoV, human bocavirus; HCoV, human coronavirus; HEV, human enterovirus; HMPV, human metapneumovirus; HPV, human parechovirus. HPVI, human parainfluenza virus; HRV, human rhinovirus; INF, influenza virus; RSV, respiratory syncytial virus.

When the patient was hospitalized.

Of the specimens that tested positive for at least one respiratory bacteria, two or more respiratory bacteria were detected in 81/220 (26.9%) specimens, of which dual detection occurred in 80/81 (98.8%) of specimens. *S pneumoniae* (170/249; 68.3%) was mostly detected in specimens with a single bacterial infection, whereas Hib (13/16; 54.8%) and *S aureus* (68/112; 60.7%) were mostly detected in specimens with two or more bacterial infections (Figure [2](#hsr2137-fig-0002){ref-type="fig"}B). The number of bacterial detections among bacteria‐positive specimens ranged between 1 and 3. Among patients with abnormal radiological findings, respiratory bacteria were most commonly detected among patients with pulmonary opacity (87/106; 90.5%).

*S pneumoniae* and *S aureus* were mostly detected during the rainy season (June to September) (Table [3](#hsr2137-tbl-0003){ref-type="table"} and Figure [3](#hsr2137-fig-0003){ref-type="fig"}B).

4. DISCUSSION {#hsr2137-sec-0017}
=============

We report the detection of respiratory viruses and bacteria among children aged younger than 5 years hospitalized with febrile ARI in Niger between January and December 2015. At least one respiratory virus or bacteria was found in 77.7% of samples tested. This proportion was similar to that reported in a previous study on the etiology of ARI in children aged younger than 5 years in Niger (78%), although on a limited number of samples.[8](#hsr2137-bib-0008){ref-type="ref"} This finding was also consistent with those of other similar studies conducted in Africa (range 55%‐70%)[21](#hsr2137-bib-0021){ref-type="ref"}, [22](#hsr2137-bib-0022){ref-type="ref"} and Asia (range 45%‐65%).[23](#hsr2137-bib-0023){ref-type="ref"}, [24](#hsr2137-bib-0024){ref-type="ref"}, [25](#hsr2137-bib-0025){ref-type="ref"}

The positivity proportion of respiratory viruses varied considerably. RSV, HPIV, HRV, HAV, and INF were the most commonly detected viruses. As reported in other studies, RSV, INF, and HMPV were mostly detected as single viral infections.[26](#hsr2137-bib-0026){ref-type="ref"}, [27](#hsr2137-bib-0027){ref-type="ref"} RSV, HRV, and HPIV were also the most predominant viruses detected in children aged younger than 5 years in a previous study conducted in Niger.[8](#hsr2137-bib-0008){ref-type="ref"} RSV is considered to be a major cause of ARI in children aged younger than 5 years,[26](#hsr2137-bib-0026){ref-type="ref"}, [28](#hsr2137-bib-0028){ref-type="ref"}, [29](#hsr2137-bib-0029){ref-type="ref"}, [30](#hsr2137-bib-0030){ref-type="ref"} and it was the most commonly detected virus also in this study (149/638; 23.3%).

Among the cases in which HPIV and HCoV were detected, HPIV type 3 and HCoV type OC43 were the predominant types, and this is consistent with previous studies.[27](#hsr2137-bib-0027){ref-type="ref"}, [31](#hsr2137-bib-0031){ref-type="ref"} In this study, INFs were detected in 8.5% of the cases, which is in agreement with findings from the national influenza surveillance[14](#hsr2137-bib-0014){ref-type="ref"} and other related studies in Africa among patients hospitalized with SARI.[18](#hsr2137-bib-0018){ref-type="ref"}, [32](#hsr2137-bib-0032){ref-type="ref"}, [33](#hsr2137-bib-0033){ref-type="ref"} A higher influenza positivity proportion has been reported among outpatients with influenza‐like illness.[13](#hsr2137-bib-0013){ref-type="ref"}, [28](#hsr2137-bib-0028){ref-type="ref"}

During the 1‐year study period, respiratory viruses were detected throughout the four seasons.[15](#hsr2137-bib-0015){ref-type="ref"} However, RSV was mostly detected during the hot and dry seasons with higher temperature and lower relative humidity,[7](#hsr2137-bib-0007){ref-type="ref"} whereas INFs were mostly detected during the cold and rainy seasons, as reported from influenza sentinel surveillance in Niger.[14](#hsr2137-bib-0014){ref-type="ref"}, [34](#hsr2137-bib-0034){ref-type="ref"} If these seasonal patterns are confirmed in multiyear studies, they could be useful for epidemic preparedness and response plans.

High colonization rates of *S pneumoniae*, *S aureus,* and Hib have been reported in children, but only a fraction of colonization events have been reported to result in disease.[35](#hsr2137-bib-0035){ref-type="ref"}, [36](#hsr2137-bib-0036){ref-type="ref"} *S pneumoniae* was detected in 39.5% of specimens, and it was the bacteria predominantly detected in our samples. However, the colonization rate found in this study was lower than that reported in a study conducted in 2014 (54.5%), which could be attributed to the introduction of the 13‐valent pneumococcal conjugate vaccination (PCV13) in Niger that same year.[37](#hsr2137-bib-0037){ref-type="ref"} The very low detection rate of Hib (2.5%) may also be attributed to the introduction of the Hib conjugate (tetanus toxoid) vaccine in the expanded immunization program in 2008 in Niger.[38](#hsr2137-bib-0038){ref-type="ref"} Uncommon respiratory bacterial pathogens including *M pneumoniae* and *C pneumoniae* were detected at a very low rate (less than 1%), and this correlates with the results reported in previous studies.[10](#hsr2137-bib-0010){ref-type="ref"}, [26](#hsr2137-bib-0026){ref-type="ref"}, [27](#hsr2137-bib-0027){ref-type="ref"}

In our study, 21.2% of children had already received antibiotics before hospitalization, and nearly all children (89.7%) received antibiotics during admission. These findings are consistent with a study from Mali, which reported a rate of antibiotics uptake of 39.8% before admission and elevated antibiotics usage (more than 95%) on admission.[39](#hsr2137-bib-0039){ref-type="ref"} The national guidelines for ARI treatment based on the Integrated Management of Childhood Illness (Manuel sur la Prise en Charge Integrée des Maladies de l\'Enfant (PCIME) (2001), retrieved from <https://apps.who.int/iris/bitstream/handle/10665/67167/WHO_FCH_CAH_00.12_fre.pdf;jsessionid=65C124F019A55837AF0B229E9AB1B21A?sequence=1> [)]{.ul} include the systematic use of antibiotics for empiric treatment to prevent superinfection. However, considering the high number of patients from whom only respiratory viruses were detected, this practice raises concern about the potentially excessive use of antibiotics---and resistance development---in Niger.[28](#hsr2137-bib-0028){ref-type="ref"}

About 15% to 17% of patients with febrile ARI also had diarrhea, were malnourished, or were coinfected with malaria. This could be explained by the fact that these infections constitute some of the leading public health concerns in Niger and are responsible for elevated childhood mortality (Annuaire des statistiques sanitaires du Niger) (2016). Retrieved from <http://www.stat-niger.org/statistique/file/Annuaires_Statistiques/snis/Annuaire_statistiques_2016.pdf>).

Our study presents some limitations. First, the study spanned over a period of only 12 months, limiting our ability to fully assess the temporal circulation pattern of the investigated agents. Due to the small sample size, we may also have been underpowered to detect small variations in the temporal distribution of the investigated agents. Second, attribution of causality remains challenging due to the lack of controls in our study. The association of pathogen detection with illness could not be well assessed, although most of the viral and bacterial pathogens identified in this study have been described in previous case control studies as causative agents of ARI.[10](#hsr2137-bib-0010){ref-type="ref"}, [39](#hsr2137-bib-0039){ref-type="ref"} In addition, we did not collect blood samples to assess whether the detection of common bacterial colonizers of the nasopharynx, such as *S pneumoniae*, were associated with invasive disease. Third, we did not record the number of patients with febrile ARI that refused enrollment, hindering our ability to estimate underenrollment. Last, given that only patients with febrile ARI were enrolled, this could have resulted in an underestimation of the RSV burden since a large proportion of RSV‐related illness is not associated with fever.[40](#hsr2137-bib-0040){ref-type="ref"}

5. CONCLUSIONS {#hsr2137-sec-0018}
==============

In this 1‐year prospective study, both viral and bacterial pathogens were detected in high proportion among hospitalized children aged younger than 5 years with febrile ARI in Niamey, Niger. However, further investigations should be carried out to assess risk factors and association of pathogens with illness. Although national guidelines for ARI treatment recommend systematic empiric antibiotic therapy, our results suggest that antibiotic use might be unnecessary in most cases, given the predominance of viral infections as potential cause of febrile ARI. Furthermore, other predisposing diseases such as malaria, malnutrition, and diarrhea may be contributory factors to febrile ARI exacerbation among hospitalized children.
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